NASCENT BIOTECH, INC.

Insiders Nascent Biotech, Inc.

Equities

NBIO

US63108Q1013

Market Closed - OTC Markets Other stock markets 20:27:14 14/06/2024 BST			5-day change	1st Jan Change
0.087 ^USD	+2.04%		+8.89%	-49.68%

04-16	Nascent Biotech, Inc. Prepares for Pivotal Phase II Research with Fresh Manufacturing Run	CI
03-19	Nascent Collaborates With Hypospray Pharma Announces Collaboration to Develop an Alternative Delivery Mechanism for Patients Who Can Benefit from Pritumumab	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Board	20/12/22	CI
Nascent Biotech, Inc. Announces the Resignation of Douglas Karas as Chief Operating Officer	14/04/21	CI
Brandon Price Resigns as Executive Vice President and Director of Nascent Biotech, Inc, Effective September 30, 2020	22/09/20	CI
Nascent Biotech Appoints Navpaul Singh as Chief Medical Consultant in Charge of Covid-19 Research	24/06/20	CI
Nascent Biotech Inc. Elects Douglas J. Karas as Director	11/04/16	CI
Nascent Biotech, Inc. Announces the Resignation of Mark Glassy as Officer and Director and Accepts the Position as Chairman of the Scientific Advisory Board	08/09/15	CI
Nascent Biotech, Inc. Announces Executive Changes	10/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW